InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Brumm Joshua T, Executive. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 25 disclosures have been logged. Split: 0 buy · 9 sells. Total volume traded: €635k. History available since 20 September 2021. The latest transaction was filed on 8 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Brumm Joshua T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
42,305 sharesOrdinary SharesSEC:0001628280-26-044884:0
45,117 sharesOrdinary SharesSEC:0001628280-25-057683:0
153,931 shares@ US$5.5443.8% of flowCommon StockSEC:0000950170-24-030479:0
9,086 shares@ US$25.8512.1% of flowCommon StockSEC:0000950170-24-029616:0
5,520 shares@ US$5.541.6% of flowCommon StockSEC:0000950170-24-024300:0
20,000 shares0Common StockSEC:0000950170-24-009406:0
51,183 shares@ US$1.032.7% of flowCommon StockSEC:0000950170-24-002280:0
7,585 shares@ US$10.724.2% of flowCommon StockSEC:0001209191-23-058327:0
358,877 shares0Common StockSEC:0001209191-23-055523:0
12,032 shares@ US$9.4116.7% of flowCommon StockSEC:0001209191-23-050169:0
7,672 shares@ US$10.414.2% of flowCommon StockSEC:0001209191-23-049357:0
20,000 shares0Common StockSEC:0001209191-23-036544:0
7,318 shares@ US$13.335.1% of flowCommon StockSEC:0001209191-23-018978:0
144,000 shares0Common StockSEC:0001209191-22-060966:0
14,200 shares@ US$1.030.8% of flowCommon StockSEC:0001209191-22-053212:0
11,836 shares@ US$13.709.1% of flowCommon StockSEC:0001209191-22-050884:0
3,480 shares@ US$14.052.8% of flowCommon StockSEC:0001209191-22-050119:0
24,118 shares0Common StockSEC:0001209191-22-041330:0
3,540 shares@ US$4.951.0% of flowCommon StockSEC:0001209191-22-037143:0
3,384 shares@ US$8.731.5% of flowCommon StockSEC:0001209191-22-018532:0
118,190 shares0Common StockSEC:0001209191-21-069420:0
3,500 shares0Common StockSEC:0001209191-21-059052:0
3,425 shares@ US$15.612.6% of flowCommon StockSEC:0001209191-21-057324:0
26,000 sharesCommon StockSEC:0001209191-16-094559:0
990 sharesCommon StockSEC:0001209191-16-088034:0
25 of 25 declarations
About Brumm Joshua T
Brumm Joshua T is a director/officer, with 25 filings in total. The 25 sampled filings cover the period from 2016-01-04 to 2026-06-23, and relate to disposals for a total of EUR 862893, with no purchases reported. He is listed at Dyne Therapeutics, Inc. as CEO & President, at CRESCENT BIOPHARMA, INC. as Chief Executive Officer, and at Versartis, Inc. as Chief Financial Officer.
